Definium Therapeutics Inc. Common Shares vs Keel Infrastructure Corp. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.9 (market cap $4.59B), while Keel Infrastructure Corp. Common Stock trades at $3.04 (market cap $1.93B). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 2.4× Keel Infrastructure Corp. Common Stock's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Keel Infrastructure Corp. Common Stock for 1 Days on average.
| DFTX | KEEL | |
|---|---|---|
Market Cap | $4.59B | $1.93B |
Volume | 2,103,937 | 30,868,523 |
Sector | Health | Technology |
52-Week High | $48.45 | $6.66 |
52-Week Low | $10.68 | $1.71 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $3.55B | $2.25B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →